Home Cart Sign in  
Chemical Structure| 54-91-1 Chemical Structure| 54-91-1

Structure of Pipobroman
CAS No.: 54-91-1

Chemical Structure| 54-91-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Pipobroman is an anti-cancer drug that probably acts as an alkylating agent.

Synonyms: PB; Vercyte

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Pipobroman

CAS No. :54-91-1
Formula : C10H16Br2N2O2
M.W : 356.05
SMILES Code : O=C(N1CCN(C(CCBr)=O)CC1)CCBr
Synonyms :
PB; Vercyte
MDL No. :MFCD00866372
InChI Key :NJBFOOCLYDNZJN-UHFFFAOYSA-N
Pubchem ID :4842

Safety of Pipobroman

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335-H351-H361
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Pipobroman

DNA

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01243944 Polycythemia Vera Phase 3 Completed - -
NCT02038036 Polycythemia Vera Phase 3 Active, not recruiting April 8, 2020 -
NCT01243944 - Completed - -
NCT05190744 Autosomal Dominant Polycystic ... More >>Kidney Disease|Nephrogenic Diabetes Insipidus|Acquired Nephrogenic Diabetes Insipidus|Congenital Nephrogenic Diabetes Insipidus Less << PHASE2 RECRUITING 2025-12-31 Mayo Clinic, Jacksonville, Flo... More >>rida, 32224, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.81mL

0.56mL

0.28mL

14.04mL

2.81mL

1.40mL

28.09mL

5.62mL

2.81mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories